TrxR1 activity levels are diagnostic for early detection of lung (39) and breast cancers (8), and TrxR1 has emerged as a target to combat drug-resistant lung cancers, for example, ethaselen (49). The gene discussed is TXNRD1; the disease is breast carcinoma.